338987 <common-name>2-[(5z)-4-oxo-5-[[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid</common-name> <description>2-[(5z)-4-oxo-5-[[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid is a chemical compound with the formula C24H23N3O5S3. With an average molecular weight of 529.70 g/mol, 2-[(5z)-4-oxo-5-[[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid is a heavy molecule.</description> <cas>623935-31-9</cas> <pubchem-id>5868739</pubchem-id> <chemical-formula>C24H23N3O5S3</chemical-formula> <weight>529.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T22:10:48Z</created-at> <updated-at type="dateTime">2026-08-30T22:10:48Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCOC1=CC=C(C=C1)C2=NN(C=C2C=C3C(=O)N(C(=S)S3)CCS(=O)(=O)O)C4=CC=CC=C4</moldb-smiles> <moldb-formula>C24H23N3O5S3</moldb-formula> <moldb-inchi>InChI=1S/C24H23N3O5S3/c1-2-13-32-20-10-8-17(9-11-20)22-18(16-27(25-22)19-6-4-3-5-7-19)15-21-23(28)26(24(33)34-21)12-14-35(29,30)31/h3-11,15-16H,2,12-14H2,1H3,(H,29,30,31)/b21-15-</moldb-inchi> <moldb-inchikey>LBGGIESGOLRAPE-QNGOZBTKSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">529.0799844</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM334880</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[(5z)-4-oxo-5-[[1-phenyl-3-(4-propoxyphenyl)pyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0289413</sync-id> <structure-inchikey>LBGGIESGOLRAPE-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400000000000000088000420000000000000000000000000001000000000000004040020000203000000200000020040000000000000000008100400000000000000000000000000880000000000000200000100003000002000000000000000000200100000000000001020100108000080001001080400000000000000000200041400000008040000000000040008000000401000000000000000000000000000000000000000000000800000000000000200900000a0200040000000000000000000000000000000000000000008000000000040000000200000000000000000040000000000040000000800000000000080010000000000200000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICCAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQHQCgAAAADAwdAKAAA AAMDBkBoAAAAAwMBBkAoAAAAAwQGAGgAAAADAwEGACgAAAADBAYAKAAAAAME CAAoAAAAAwIHACgAAAADAwYAKAAAAAMEEAAoAAAAAwIQACAAAAACBgBgAAAA AgIGAGAAAAACAhAAIAAAAAYIACgAAAADAggAKAAAAAMCCABgAAAAAQEGQCgA AAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAA AAMDAQsAAQABAgACAwADBCAEBWgMBQZoDAYHaAwHCGgMCAloDAcKIAoLaAwL DGgMDA1oDA0OaAwODyAPECgCEBEgERIoAhETIBMUIBQVKAIUFgATFwAXGAAY GQAZGggCGRsIAhkcAAwdIB0eaAweH2gMHyBoDCAhaAwhImgMCQRoDA4KaAwW EAAiHWgMQgQAAAAGBAkIBwYFBQsKDg0MBREQFhQTBh4fICEiHRcEAAAAAAAA ABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:39:36Z</structure-indexed-at> </compound>